Heart issues are more prevalent in the elderly especially outside metro cities A seasoned cardiologist shares potential ...
The association between amyloidosis and aortic valve stenosis has attracted considerable international attention. However, ...
JenaValve Technology, Inc., developer and manufacturer of the Trilogy ® Transcatheter Heart Valve (THV) System, today announced the appointment of Edward (Ed) Sarnowski as Chief Technology Officer. Ed ...
Transcatheter aortic valve replacement (TAVR) with a self-expanding valve still worked out better, at least in terms of ...
The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide.
The totality of data suggests that routine PCI prior to TAVI is not warranted in the majority of cases, a meta-analysis shows ...
Four-year-old Daija Mae Jo Kent loves dance parties, horses and Sesame Street. Funny, affectionate and full of energy, the kind of child who gives hugs and kisses and tries to make people laugh. Now ...
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time ...
Cardiovascular drug developer Kardigan on Tuesday filed for an initial public offering in the United States.
Motoring Chronicle on MSN
Aortic stenosis and AIDS: How DVLA has quietly rewritten its medical forms for 2026
The DVLA has quietly rewritten the rulebook on which medical conditions you must report when you renew your driving licence, ...
The deal gives Boston Scientific a 34% stake in MiRus and an option to buy its TAVR business for an additional $3 billion ...
Kardigan plans to use the IPO funds to push its three in-licensed, mid-to-late-stage heart health therapies further down the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results